Candida Infections, Glycemic Dysregulation, and the Future of Regenerative Dentistry

The evolution of regenerative dentistry and future oral health technologies has fundamentally shifted clinical priorities from symptom management toward biologic optimization and precision-based care. As advanced regenerative materials, biologics, and tissue-engineering strategies become increasingly integrated into dental practice, the success of these therapies depends heavily on the host’s systemic and local biologic environment [1]. Within this context, oral candidiasis should be re-evaluated not merely as a localized fungal infection, but as a clinically accessible biomarker of metabolic dysregulation that directly impacts regenerative capacity.

Candida species are commensal yeast-type fungi that inhabit the oral cavity and other mucosal surfaces as part of the normal oral microbiome. In healthy individuals, this microbial equilibrium is maintained through intact immune surveillance, adequate salivary flow, and stable epithelial turnover [2]. Disruption of this balance, most commonly through hyperglycemia, salivary dysfunction, autoimmune diseases (Figure 1), and/or immune-compromised patients, can lead to Candida albicans overgrowth and the development of oral candidiasis. While Candida carriage is common even among asymptomatic adults, the transition from colonization to clinical disease reflects underlying host vulnerability that is highly relevant to regenerative outcomes [2,3].

Figure 1. Patient with Oral candidiasis and Pemphigus (autoimmune disease), biopsy proven

What the evidence says

A growing body of evidence demonstrates a strong association between glycemic dysregulation and increased oral Candida burden. Elevated blood glucose levels translate into increased salivary glucose, providing a direct nutrient source for fungal proliferation. Importantly, this association is not limited to overt diabetes; individuals with prediabetes already demonstrate higher oral Candida carriage compared with normoglycemic controls [4]. From a future-oriented dental perspective, this finding is critical, as early metabolic changes may silently undermine wound healing, graft integration, and tissue regeneration long before systemic disease is formally diagnosed.

Diabetes-related xerostomia further compounds this risk. Reduced salivary flow, altered salivary pH, and qualitative changes in salivary proteins diminish the protective functions of saliva, including mechanical cleansing, antimicrobial activity, and buffering capacity [5]. These alterations promote fungal adhesion and biofilm formation on oral mucosa, teeth, dentures, and restorative materials. For regenerative dentistry, where biomaterial–tissue interfaces are essential, a compromised salivary environment may increase the risk of infection, delayed healing, and biologic failure [5,6].

Recurrent or persistent oral candidiasis warrants particular clinical attention. Multiple episodes over short intervals, lesions that fail to resolve with standard therapy, or unusually severe presentations may signal unrecognized metabolic imbalance. Poor glycemic control has been consistently associated with increased frequency and severity of oral fungal infections, with higher long-term glucose measures (HbA1c) correlating with greater disease burden [6,7]. These patterns position oral candidiasis as a potential early-warning signal, one that can be detected chairside, prompting timely metabolic evaluation before regenerative procedures are undertaken.

Certain patient populations merit heightened vigilance. Middle-aged and older adults, denture wearers, and individuals with known risk factors for impaired healing are more likely to exhibit Candida overgrowth in the presence of glycemic dysregulation [8]. Denture surfaces provide a reservoir for fungal colonization, and when combined with diabetes-related immune dysfunction, can contribute to chronic mucosal inflammation. In the regenerative era, such chronic inflammatory states are incompatible with predictable tissue engineering, implant integration, and soft-tissue regeneration [9].

Like what you’re learning?  Download a brochure for our online, postgraduate Oral Pathology and Radiology certificate program.

New technologies in dentistry for this condition

Emerging technologies in dentistry further amplify the importance of recognizing oral candidiasis as a systemic signal rather than an isolated condition.

• Advances in salivary diagnostics, point-of-care biosensors, and artificial intelligence, driven by risk stratification, offer new opportunities to integrate oral findings with systemic health assessment [10]. Saliva-based glucose monitoring, inflammatory biomarker analysis, and microbiome profiling may soon allow clinicians to identify patients with subclinical metabolic dysfunction during routine dental visits. In this framework, recurrent Candida infections could serve as a trigger for advanced diagnostic pathways, aligning dental care with precision medicine principles.
• Regenerative dentistry increasingly relies on biologics such as growth factors, platelet concentrates, stem-cell–based therapies, and bioactive scaffolds. The efficacy of these interventions is tightly linked to angiogenesis, immune modulation, and cellular responsiveness, all of which are impaired in hyperglycemic states [11].

Chronic inflammation, microvascular compromise, and immune dysregulation associated with diabetes create a biologic environment that is hostile to regeneration. Oral candidiasis, therefore, should be interpreted as a visible manifestation of these deeper biologic constraints.

From a clinical decision-making standpoint, incorporating fungal risk assessment into regenerative treatment planning represents an important shift. Identification of active or recurrent candidiasis should prompt not only antifungal management but also consideration of systemic optimization prior to advanced procedures. Collaboration with medical colleagues to address glycemic control, hydration status, and salivary function enhances biologic readiness and may improve long-term regenerative outcomes [6,11]. This interdisciplinary approach reflects the future direction of dental medicine as an integral component of comprehensive healthcare.

Conclusion

In conclusion, oral candidiasis occupies a critical intersection between infectious disease, systemic metabolism, and regenerative potential. As dentistry continues to evolve toward biologically driven and technology-enabled care, fungal infections should be recognized as clinically meaningful indicators of host environment suitability for regeneration. Dentists and oral medicine clinicians are uniquely positioned to identify these signals early, leverage emerging diagnostic technologies, and guide patients toward metabolic optimization. By reframing oral candidiasis as a biomarker rather than a nuisance condition, regenerative dentistry can advance toward more predictable, personalized, and successful therapeutic outcomes.

Postgraduate Oral Pathology and Radiology Certificate

Learn more about the clinical and didactic skills necessary to evaluate and manage patients with oral diseases by enrolling in Herman Ostrow School of USC’s online, competency-based certificate program in Oral Pathology and Radiology.

References

1. Chen FM, Liu X. Advancing biomaterials of human origin for tissue engineering. Prog Polym Sci. 2016;53:86–168.
2. Singh A, Verma R, Murari A, Agrawal A. Oral candidiasis: An overview. J Oral Maxillofac Pathol. 2014;18(Suppl 1):S81–S85.
3. Samaranayake LP. Host factors and oral candidosis. Oral Dis. 1998;4(1):1–12.
4. Javed F, Ahmed HB, Mehmood A, et al. Association between glycemic status and oral Candida carriage in patients with prediabetes. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(1):53–58.
5. Mohammadi F, Javaheri MR, Nekoeian S, Dehghan P. Identification of Candida species in the oral cavity of diabetic patients. Curr Med Mycol. 2016;2(2):1–7.
6. Mohammed L, Jha G, Malasevskaia I, et al. The interplay between sugar and yeast infections. Cureus. 2021;13(2):e13407.
7. Hill LV, Tan MH, Pereira LH, Embil JA. Association of oral candidiasis with diabetic control. J Clin Pathol. 1989;42(5):502–505.
8. Al Mubarak S, Robert AA, Baskaradoss JK, et al. Prevalence of oral Candida infections in periodontitis patients with type 2 diabetes mellitus. J Infect Public Health. 2013;6(4):296–301.
9. Coco BJ, Bagg J, Cross LJ, et al. Mixed Candida albicans and Candida glabrata populations in the oral cavity of denture wearers. Oral Microbiol Immunol. 2008;23(5):377–383.
10. Zhang Y, Cheng X, Li X, et al. Saliva-based biosensors for monitoring systemic health. Biosens Bioelectron. 2020;166:112458.
11. Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity. Front Biosci. 2008;13:1227–1239.